ATE485849T1 - Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit - Google Patents

Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit

Info

Publication number
ATE485849T1
ATE485849T1 AT06838790T AT06838790T ATE485849T1 AT E485849 T1 ATE485849 T1 AT E485849T1 AT 06838790 T AT06838790 T AT 06838790T AT 06838790 T AT06838790 T AT 06838790T AT E485849 T1 ATE485849 T1 AT E485849T1
Authority
AT
Austria
Prior art keywords
coatings
methods
devices
production
polymer compositions
Prior art date
Application number
AT06838790T
Other languages
English (en)
Inventor
Mark Meyerhoff
Wansik Cha
Sang-Yeul Hwang
Melissa Reynolds
Original Assignee
Univ Michigan
Michigan Critical Care Consult
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan, Michigan Critical Care Consult filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE485849T1 publication Critical patent/ATE485849T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/082—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/14—Post-treatment to improve physical properties
    • A61L17/145—Coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/30—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/10—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0047—Enzymes, e.g. urokinase, streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
  • Paints Or Removers (AREA)
  • Electrotherapy Devices (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT06838790T 2005-12-02 2006-12-01 Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit ATE485849T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74160105P 2005-12-02 2005-12-02
PCT/US2006/046013 WO2007064895A2 (en) 2005-12-02 2006-12-01 Polymer compositions, coatings and devices, and methods of making and using the same

Publications (1)

Publication Number Publication Date
ATE485849T1 true ATE485849T1 (de) 2010-11-15

Family

ID=38092828

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06838790T ATE485849T1 (de) 2005-12-02 2006-12-01 Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit

Country Status (8)

Country Link
US (1) US20090287072A1 (de)
EP (1) EP1968664B1 (de)
JP (1) JP2009518069A (de)
CN (1) CN101378792A (de)
AT (1) ATE485849T1 (de)
CA (1) CA2632224A1 (de)
DE (1) DE602006017886D1 (de)
WO (1) WO2007064895A2 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006249323B2 (en) 2005-05-27 2012-08-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
WO2007005758A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Methods , compositions and devices for promoting angiogenesis
US8273063B2 (en) 2006-05-30 2012-09-25 Yossi Gross Implantable pump for drug delivery to treat erectile dysfunction
US8152711B2 (en) 2007-03-21 2012-04-10 Yossi Gross Implantable peristaltic pump to treat erectile dysfunction
DE102007032686A1 (de) * 2007-07-13 2009-01-15 Biotronik Vi Patent Ag Stent mit einer Beschichtung
EP2170157B1 (de) * 2007-07-26 2016-09-07 Duke University Messung der menge gebundenen und kombinierten stickstoffoxids im blut
HU0800031D0 (en) * 2008-01-16 2008-03-28 Biotech Hungary Kutato Es Fejl Method for stabilization of s-nitrosoglutathione and composition prepared by the same
US20090198271A1 (en) * 2008-01-31 2009-08-06 Rainbow Medical Ltd. Electrode based filter
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US8626299B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US7818062B2 (en) 2008-01-31 2010-10-19 Ed Tech Medical Ltd. Peristaltic pump for treatment of erectile dysfunction
US9005106B2 (en) 2008-01-31 2015-04-14 Enopace Biomedical Ltd Intra-aortic electrical counterpulsation
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
WO2010022132A2 (en) * 2008-08-19 2010-02-25 The Regents Of The University Of Michigan Biocompatible coatings, and methods of making and using the same
EP2393526B1 (de) 2009-02-09 2014-04-09 St. Jude Medical, Inc. Verbesserung der biokompatibilität einer medizinischen vorrichtung
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
JP5798345B2 (ja) * 2011-03-11 2015-10-21 学校法人昭和薬科大学 ＴＡＦＩａタンパク質に対して阻害活性を有する化合物
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
WO2013035092A2 (en) 2011-09-09 2013-03-14 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US9386991B2 (en) 2012-02-02 2016-07-12 Rainbow Medical Ltd. Pressure-enhanced blood flow treatment
CN104394923B (zh) * 2012-03-30 2017-07-14 密执安大学评议会 一氧化氮递送装置
US10449321B2 (en) 2012-03-30 2019-10-22 The Regents Of The University Of Michigan Gas delivery devices
CN105307695B (zh) * 2013-02-07 2017-07-18 密执安大学评议会 具有提高稳定性的抗血栓/杀菌s‑亚硝基‑n‑乙酰基青霉胺(snap)掺杂氧化氮释放聚合物
US20170224872A1 (en) * 2013-09-12 2017-08-10 Ronen Shavit Liners for medical joint implants with improved wear-resistance
CN105899166B (zh) 2013-11-06 2018-07-06 伊诺佩斯生医有限公司 无线型血管内基于支架的电极
EP3122393B1 (de) * 2014-03-25 2020-04-22 Orthopaedic Innovation Centre Inc. Selektives lasersinterverfahren (sls) zur herstellung von antibiotika-freisetzenden medizinischen implantaten
CN104673096B (zh) * 2014-08-12 2017-05-17 西南交通大学 一种具有一氧化氮(no)催化活性的涂层的制备方法
PL3419683T3 (pl) * 2016-02-25 2022-01-17 The Regents Of The University Of Michigan Preparaty i zestawy generujące tlenek azotu
CN107224621A (zh) * 2016-03-23 2017-10-03 成都交大麦迪克科技有限公司 一种具有内皮仿生功能涂层及其制备方法
US11186681B2 (en) * 2016-10-07 2021-11-30 The University Of North Carolina At Chapel Hill S-Nitrosothiol-mediated hyperbranched polyesters
CN106581742B (zh) * 2016-11-22 2019-06-21 成都迈德克科技有限公司 一种在钛合金表面构建no催化型纳米涂层的方法
CN108578772B (zh) * 2018-05-23 2020-09-08 西南交通大学 一种用于提升生物相容性的血液接触材料制备方法及血液接触材料
CN109481085A (zh) * 2018-12-25 2019-03-19 天津市胸科医院 一种施加有药物的介入瓣膜
MX2021015189A (es) 2019-06-10 2022-03-17 Univ Michigan Regents Dispositivos de inserción de catéteres.
CN111450326A (zh) * 2020-03-09 2020-07-28 西南交通大学 一种载硒唑酮血管支架药物涂层及其制备方法
CN111773440B (zh) * 2020-05-22 2026-04-17 南京大学 一种基于类酶催化反应的抗凝血材料
CN114129780B (zh) * 2020-09-03 2022-06-28 天津大学 一种光控释放一氧化氮的复合水凝胶的制备及应用
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator
JP7717991B2 (ja) * 2022-05-12 2025-08-04 ステリル ステイト，エルエルシー 一酸化窒素前駆体及びそれを形成するための多成分組成物
WO2023234962A1 (en) * 2022-06-01 2023-12-07 Selenbio, Inc. Organic diselenide composition
CN115317677B (zh) * 2022-08-24 2023-06-23 天津大学温州安全(应急)研究院 一种高抗凝ecmo和体外循环耗材
CN115998942A (zh) * 2023-02-09 2023-04-25 再造再生医学科技(杭州)有限公司 用于肿瘤区血管的栓塞封堵材料、制备方法及应用
CN119367609B (zh) * 2024-11-01 2025-11-11 成都奇璞生物科技有限公司 一种人工角膜及其制备方法
CN120168706B (zh) * 2025-03-28 2025-08-29 山东省循证医学研究院有限公司 一种负载pdrn的动态交联多糖基水凝胶及其制备方法
CN121003729B (zh) * 2025-10-28 2025-12-23 四川大学 一种近红外光介导杂化水凝胶多生物活性协同促组织修复材料及其制备方法和应用

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933589A (en) * 1975-03-20 1976-01-20 Owens-Illinois, Inc. Chemical immobilization of enzymes
US4166820A (en) * 1977-08-04 1979-09-04 Spallholz Julian E Selenium compounds
DE2847441A1 (de) * 1978-11-02 1980-05-22 Basf Ag Imidazol-kupferkomplexverbindungen
US4341757A (en) * 1980-09-02 1982-07-27 Nutrition 21 Stable isotopic immunoassay method employing non-radioactive selenium label
US4613468A (en) * 1984-01-12 1986-09-23 Gte Laboratories Incorporated Method for preparing aromatic and olefinic organoselenium and organotellurium compounds
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
US4959135A (en) * 1987-02-25 1990-09-25 Aquanautics Corporation Polyalkylamine complexes for ligand extraction and generation
US4952289A (en) * 1988-05-09 1990-08-28 Aquanautics Corporation Macrocyclic amine complexes for ligand extraction and generation
US5283339A (en) * 1988-11-23 1994-02-01 California Institute Of Technology Immobilized metal aqueous two-phase extraction and precipitation
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5386012A (en) * 1990-02-06 1995-01-31 Strid; Lars Growth factor in connection with artificial implants
DE4004900A1 (de) * 1990-02-16 1991-08-22 Merck Patent Gmbh Nitratreduktase aus hefen, ihre herstellung und verwendung
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines
US5185376A (en) * 1991-09-24 1993-02-09 The United States Of America As Represented By The Department Of Health And Human Services Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof
CA2129630C (en) * 1992-02-07 2003-09-23 Anthony E. Bolton Method of increasing the concentration of nitric oxide in blood
US5389675A (en) * 1992-03-27 1995-02-14 The United States Of America As Represented By The Department Of Health And Human Services Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
US5814666A (en) * 1992-04-13 1998-09-29 The United States As Represented By The Department Of Health And Human Services Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US6200558B1 (en) * 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5632981A (en) * 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US6284752B1 (en) * 1993-08-25 2001-09-04 Anormed Inc. Pharmaceutical compositions comprising metal complexes
GB9317686D0 (en) * 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
US6087479A (en) * 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
US6255277B1 (en) * 1993-09-17 2001-07-03 Brigham And Women's Hospital Localized use of nitric oxide-adducts to prevent internal tissue damage
EP0722320B1 (de) * 1993-10-08 2000-07-19 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Verwendung von stickstoffoxid freisetzenden verbindungen als arzneimittel zur strahlungssensibilisation fur hypoxische zellen
US5840759A (en) * 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
US5482925A (en) * 1994-03-17 1996-01-09 Comedicus Incorporated Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
US5783454A (en) * 1994-05-17 1998-07-21 Spallholz; Julian E. Method for the preparation of free radical pharmaceuticals using selenium conjugates
US6077714A (en) * 1994-05-17 2000-06-20 Spallholz; Julian E. Method for the preparation of free radical pharmaceuticals diagnostics and devices using selenium conjugates
US6747062B2 (en) * 1994-09-26 2004-06-08 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Regulation of wound healing by nitric oxide
AU6104596A (en) * 1995-06-07 1996-12-30 Michael C. Trachtenberg Enzyme systems for gas processing
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US6033368A (en) * 1996-03-28 2000-03-07 Nitromed, Inc. Condensate colorimetric nitrogen oxide analyzer
US6232434B1 (en) * 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5858792A (en) * 1996-08-22 1999-01-12 University Of South Florida Method for measuring nitrite and nitrate in aqueous medium
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5855618A (en) * 1996-09-13 1999-01-05 Meadox Medicals, Inc. Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin
US5972338A (en) * 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
WO1999009912A1 (en) * 1997-08-26 1999-03-04 Technion Research And Development Foundation Ltd. Intravascular apparatus and method
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6119028A (en) * 1997-10-20 2000-09-12 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces
US6682732B1 (en) * 1998-08-28 2004-01-27 The University Of Bath Treatment of lesions
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6299980B1 (en) * 1998-09-29 2001-10-09 Medtronic Ave, Inc. One step lubricious coating
US6379691B1 (en) * 1998-09-29 2002-04-30 Medtronic/Ave, Inc. Uses for medical devices having a lubricious, nitric oxide-releasing coating
US6598546B2 (en) * 2000-02-11 2003-07-29 Thomson Alexander Access opening closure device
US6636652B1 (en) * 1999-08-02 2003-10-21 The Regents Of The University Of Michigan Optical sensors for the detection of nitric oxide
US20030083383A1 (en) * 1999-08-16 2003-05-01 Spallholz Julian E. Method of using synthetic L-Se-methylselenocysteine as a nutriceutical and a method of its synthesis
ATE431165T1 (de) * 2000-01-25 2009-05-15 Edwards Lifesciences Corp Bioaktive beschichtungen zur vermeidung von gewebewachstum auf künstlichen herzklappen
AU4757901A (en) * 2000-03-20 2001-10-03 Novovascular Inc Matrices containing nitric oxide donors and reducing agents and their use
US20040047852A1 (en) * 2001-03-02 2004-03-11 Kennedy Thomas Preston Method of treating cancer
US6270779B1 (en) * 2000-05-10 2001-08-07 United States Of America Nitric oxide-releasing metallic medical devices
US6403788B1 (en) * 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
US6410622B1 (en) * 2000-09-11 2002-06-25 Gregory W. Endres Method of preventing fouling organisms in marine environments and polymer-bound nitric oxide/nitric oxide-releasing compositions usable therefor
US6746773B2 (en) * 2000-09-29 2004-06-08 Ethicon, Inc. Coatings for medical devices
AU2002239436B2 (en) * 2000-10-31 2007-04-26 Cook Medical Technologies Llc Coated implantable medical device
US6780849B2 (en) * 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US7048939B2 (en) * 2001-04-20 2006-05-23 The Board Of Trustees Of The Leland Stanford Junior University Methods for the inhibition of neointima formation
US6660034B1 (en) * 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
US6977138B2 (en) * 2001-07-24 2005-12-20 Massachusetts Institute Of Technology Reactive polymer coatings
US6841166B1 (en) * 2001-08-21 2005-01-11 The Regents Of The University Of Michigan Nitric oxide-releasing polymers incorporating diazeniumdiolated silane derivatives
US20030065377A1 (en) * 2001-09-28 2003-04-03 Davila Luis A. Coated medical devices
US6703046B2 (en) * 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
WO2003086282A2 (en) * 2002-04-05 2003-10-23 Nitromed, Inc. Nitric oxide donors, compositions and methods of use
US7105175B2 (en) * 2002-06-19 2006-09-12 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled delivery of a therapeutic agent
US20050008676A1 (en) * 2002-12-19 2005-01-13 Yongxing Qiu Medical devices having antimicrobial coatings thereon
US20040215313A1 (en) * 2003-04-22 2004-10-28 Peiwen Cheng Stent with sandwich type coating
WO2004112864A2 (en) * 2003-06-19 2004-12-29 Vascular Therapies Llc Medical devices and methods for regulating the tissue response to vascular closure devices
US20050033417A1 (en) * 2003-07-31 2005-02-10 John Borges Coating for controlled release of a therapeutic agent
US20050033263A1 (en) * 2003-08-07 2005-02-10 Medtronic-Minimed, Inc. System and method for restenosis mitigation
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
AU2006269657B2 (en) * 2005-05-24 2012-04-19 Selenbio, Inc. Selenium-based biocidal formulations and methods of use thereof
WO2007005910A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Nitric oxide coatings for medical devices
WO2007005758A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Methods , compositions and devices for promoting angiogenesis
WO2007005759A2 (en) * 2005-06-30 2007-01-11 Mc3, Inc. Analyte sensors and compositions for use therein
US20070196428A1 (en) * 2006-02-17 2007-08-23 Thierry Glauser Nitric oxide generating medical devices
WO2010080086A1 (en) * 2009-01-12 2010-07-15 Selenium, Ltd. Anti-microbial orthodontic compositions and appliances and methods of production and use thereof

Also Published As

Publication number Publication date
EP1968664A2 (de) 2008-09-17
WO2007064895A2 (en) 2007-06-07
CN101378792A (zh) 2009-03-04
US20090287072A1 (en) 2009-11-19
DE602006017886D1 (de) 2010-12-09
CA2632224A1 (en) 2007-06-07
WO2007064895A3 (en) 2008-04-10
EP1968664B1 (de) 2010-10-27
JP2009518069A (ja) 2009-05-07

Similar Documents

Publication Publication Date Title
DE602006017886D1 (de) Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
ATE528989T1 (de) Kristalline feste rasagilin-base
WO2007019439A3 (en) Block copolymer compositions and uses thereof
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
WO2006116424A3 (en) Paintable nanofiber coatings
TNSN07195A1 (en) Potentiators of glutamate receptors
GB0712287D0 (en) Antimicrobial Conjugates
WO2008127226A3 (en) P13 kinase antagonists
WO2012080284A3 (en) Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
TW200732349A (en) Anti-OX40L antibodies and methods using same
WO2010123919A3 (en) Piperidine inhibitors of janus kinase 3
ATE492514T1 (de) Pulverförmige kalkzusammensetzung, herstellungsverfahren dafür und verwendung davon
ZA200802725B (en) Novel 1-AZA bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders
EA200600321A1 (ru) βd-КРИСТАЛЛИЧЕСКАЯ ФОРМА ГИДРОХЛОРИДА ИВАБРАДИНА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ
WO2007031454A3 (en) Coating compositions comprising a latent activator for marking substrates
BRPI0512820A (pt) composição de matéria, e método de revestir um metal
WO2008111096A3 (en) Novel prodrugs
WO2006093965A3 (en) Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof
WO2008073863A3 (en) Preparation and utility of substituted allylamines
TW200744612A (en) New combination
WO2006091836A8 (en) Formulations of ladostigil tartrate
WO2007059116A3 (en) Geldanamycin derivatives and pharmaceutical compositions thereof
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
WO2006060542A3 (en) Formulations of substituted benzoxazoles

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties